Showing 4 of 4 recruiting trials for “Idiopathic aplastic anemia”
JAK1/2 Inhibitor Ruxolitinib for Relapsed/Refractory Immune Bone Marrow Failure
👨⚕️ Emma M Groarke, M.D., National Heart, Lung, and Blood Institute (NHLBI)📍 1 site📅 Started Feb 2024View details ↗
Haploidentical Allogeneic Hematopoietic Stem Cell Transplantation With Post-transplant Cyclophosphamide in Patients With Acquired Refractory Aplastic Anemia or in Relapse After Immunosuppression
Natural History of Acquired and Inherited Bone Marrow Failure Syndromes
👨⚕️ Emma M Groarke, M.D., National Heart, Lung, and Blood Institute (NHLBI)📍 1 site📅 Started Oct 2021View details ↗
Lung and Bone Marrow Transplantation for Lung and Bone Marrow Failure
Get alerts when new trials open
Create a free account to follow conditions and receive trial notifications.
Create free account →